Staar Surgical [STAA] vs Pulse Biosciences [PLSE] Detailed Stock Comparison

Staar Surgical Company

NASDAQ
Loading...

Pulse Biosciences Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Staar Surgical Company wins in 13 metrics, Pulse Biosciences Inc. wins in 5 metrics, with 0 ties. Staar Surgical Company appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Staar Surgical Company Pulse Biosciences Inc. Better
P/E Ratio (TTM) 49.73 N/A N/A
Price-to-Book Ratio 3.58 20.17 Staar Surgical Company
Debt-to-Equity Ratio 11.14 9.34 Pulse Biosciences Inc.
PEG Ratio -1.07 -27.88 Staar Surgical Company
EV/EBITDA -28.99 -20.53 Pulse Biosciences Inc.
Profit Margin (TTM) -33.60% -54.00% Staar Surgical Company
Operating Margin (TTM) -18.87% -6,914.02% Staar Surgical Company
Return on Equity -21.70% -74.45% Staar Surgical Company
Return on Assets (TTM) -5.95% -42.37% Staar Surgical Company
Free Cash Flow (TTM) $-40.05M $-54.46M Staar Surgical Company
1-Year Return 66.10% 54.53% Staar Surgical Company
Price-to-Sales Ratio (TTM) 5.15 4,658.22 Staar Surgical Company
Enterprise Value $1.08B $1.56B Pulse Biosciences Inc.
EV/Revenue Ratio 4.53 4,449.07 Staar Surgical Company
Gross Profit Margin (TTM) 75.68% 1.52% Staar Surgical Company
Revenue per Share (TTM) $5 $0 Staar Surgical Company
Earnings per Share (Diluted) $-1.62 $-1.08 Pulse Biosciences Inc.
Beta (Stock Volatility) 1.04 1.69 Staar Surgical Company
Short % of Float 27.18% 16.20% Pulse Biosciences Inc.

Staar Surgical Company vs Pulse Biosciences Inc. Stock Performance Analysis

Loading Price Chart...

STAA
PLSE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Staar Surgical Company0.00%-5.31%-11.54%56.91%20.42%20.21%
Pulse Biosciences Inc.6.38%4.35%5.58%18.74%83.44%93.58%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Staar Surgical Company66.10%-46.07%-80.50%419.60%454.10%273.29%
Pulse Biosciences Inc.54.53%288.68%40.54%457.67%490.07%490.07%

Performance & Financial Health Analysis: Staar Surgical Company vs Pulse Biosciences Inc.

MetricSTAAPLSE
Market Information
Market Cap i$1.23B$1.65B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,616,119241,710
90 Day Avg. Volume i1,357,960269,653
Last Close$28.37$25.92
52 Week Range$15.59 - $35.87$12.56 - $28.53
% from 52W High-20.91%-9.13%
All-Time High$163.08 (Sep 06, 2021)$45.82 (Feb 08, 2021)
% from All-Time High-82.60%-43.43%
Growth Metrics
Quarterly Revenue Growth0.18%2.07%
Quarterly Earnings Growth0.18%N/A
Financial Health
Profit Margin (TTM) i-0.34%-0.54%
Operating Margin (TTM) i-0.19%-69.14%
Return on Equity (TTM) i-0.22%-0.74%
Debt to Equity (MRQ) i11.149.34
Cash & Liquidity
Book Value per Share (MRQ)$6.97$1.19
Cash per Share (MRQ)$3.79$1.19
Operating Cash Flow (TTM) i$-34,230,000$-54,122,000
Levered Free Cash Flow (TTM) i$14.61M$-29,515,876
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Staar Surgical Company vs Pulse Biosciences Inc.

MetricSTAA (Apr 24, 2026)PLSE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i49.73N/A
Forward P/E i32.36-27.88
PEG Ratio i-1.07-27.88
Price to Sales (TTM) i5.154,658.22
Price to Book (MRQ) i3.5820.17
Market Capitalization
Market Capitalization i$1.23B$1.65B
Enterprise Value i$1.08B$1.56B
Enterprise Value Metrics
Enterprise to Revenue i4.534,449.07
Enterprise to EBITDA i-28.99-20.53
Risk & Other Metrics
Beta i1.041.69
Book Value per Share (MRQ) i$6.97$1.19

Financial Statements Comparison: Staar Surgical Company vs Pulse Biosciences Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSTAA (2025)PLSE (2025)
Revenue/Sales i239.44M350,000
Cost of Goods Sold i57.02M539,000
COGS % of Revenue i23.8%154.0%
Gross Profit i182.42M-189,000
Gross Margin i76.2%-54.0%
Research & Development i40.06M44.72M
Operating Income (EBIT) i-45.95M-76.94M
Operating Margin i-19.2%-21,982.6%
EBITDA i5.95M-75.87M
EBITDA Margin i2.5%-21,676.6%
Pre-Tax Income i-82.26M-72.78M
Pre-Tax Income % of Revenue i-34.4%-20,794.6%
Income Tax i-1.82MN/A
Income Tax % of Revenue i-0.8%0.0%
Net Income (Profit) i-80.45M-72.78M
Profit Margin i-33.6%-20,794.6%

Balance Sheet & Liquidity Metrics

MetricSTAA (2025)PLSE (2025)
Cash & Equivalents i153.15M80.74M
Total Current Assets i311.55M83.42M
Total Current Assets % of Revenue i130.1%23,834.6%
Total Current Liabilities i68.50M7.92M
Total Current Liabilities % of Revenue i28.6%2,263.7%
Long-Term Debt i32.48M5.96M
Long-Term Debt % of Revenue i13.6%1,702.9%
Total Shareholders Equity i344.18M80.66M
Retained Earnings i-148.02M-463.28M
Retained Earnings % of Revenue i-61.8%-132,366.0%
Property, Plant & Equipment i773,0007.64M

Cash Flow Statement Comparison

MetricSTAA (2025)PLSE (2025)
Operating Cash Flow i-55.45M-49.76M
Operating Cash Flow % of Revenue i-23.2%-14,217.1%
Capital Expenditures i-5.82M-315,000
Free Cash Flow i-40.05M-54.46M
FCF Margin i-16.7%-15,559.1%
Debt Repayment i-42,000N/A
Common Stock Repurchase i-7.98MN/A

Short Interest & Institutional Ownership Analysis

MetricSTAAPLSE
Shares Short i7.73M2.92M
Short Ratio i6.1811.20
Short % of Float i27.18%16.20%
Shares Outstanding i49.40M67.84M
Float Shares i29.79M17.79M
% Held by Insiders i0.60%73.70%
% Held by Institutions i109.60%9.52%
% Held by Public i-10.20%16.78%

Dividend Analysis & Yield Comparison: Staar Surgical Company vs Pulse Biosciences Inc.

MetricSTAAPLSE
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A